,,iv  #aaf? ,,congress  #a/ ,session    
,h4 ,,con4 ,,res4 #ee  ,,9 ,,! ,,h\se   
,,( ,,repres5tatives  ,july #bd1        
#bjai,mr4 ,burgess submitt$ ! foll[+    
concurr5t resolution2 :i* 0 ref]r$ to ! 
,committee on ,en]gy & ,comm]ce1 & 9    
addition to ! ,committee on ,ways &     
,means1 = a p]iod to be subsequ5tly     
det]m9$ by ! ,speak]1 9 ea* case =      
consid]ation ( su* provisions z fall )9 
! jurisdiction ( ! committee conc]n$    
,,concurr5t ,,resolution  ,express+ !   
s5se ( ,congress on ! ne$ to in=m       
,am]ican consum]s ) m balanc$ pur*as+   
in=mation = prescription drugs ?r\gh !  
disclosure ( price in=mation 9          
direct-to-consum] 7,,dtc7 adv]tisem5ts4 
,:]eas1 on ,june #ac1 #bjag1 ! ,u4,s4   
,s5ate ,committee on ,heal?1 ,education1
 ,labor1 & ,p5sions held a he>+ entitl$1
 ,! ,co/ ( ,prescription ,drugs3 ,h[ !  
,drug ,deliv]y ,sy/em ,affects ,:at     
,pati5ts ,pay2 ,:]eas1 on ,octob] #ag1  
#bjag1 ! ,u4,s4 ,s5ate ,committee on    
,heal?1 ,education1 ,labor1 & ,p5sions  

held a he>+ entitl$1 ,! ,co/ (          
,prescription ,drugs3 ,h[ ! ,drug       
,deliv]y ,sy/em ,affects ,:at ,pati5ts  
,pay1 ,"p ,,ii2 ,:]eas1 on ,decemb] #ab1
 #bjag1 ! ,u4,s4 ,s5ate ,committee on   
,heal?1 ,education1 ,labor1 & ,p5sions  
held a he>+ entitl$1 ,! ,co/ (          
,prescription ,drugs3 ,an ,exam9ation ( 
,! ,national ,academies ( ,sci5ces1     
,eng9e]+1 & ,m$ic9e ,report ,mak+       
,m$ic9es ,af=dable3 ,a ,national        
,imp]ative2 ,:]eas1 on ,decemb] #ac1    
#bjag1 ! ,u4,s4 ,h\se ( ,repres5tatives 
,committee on ,en]gy & ,comm]ce1        
,subcommittee on ,heal?1 held a he>+ on 
,exam9+ ! ,drug ,supply ,*a92 ,:]eas1 on
 ,may #aa1 #bjah1 ,presid5t ,donald     
,trump & ,heal? & ,human ,s]vices       
,secret>y ,alex ,az> introduc$ !        
,am]ican ,pati5ts ,fir/ bluepr9t to br+ 
d[n prescription drug prices2 ,:]eas    
,am]ican pati5ts des]ve m transp>5cy &  
in=mation to bett] position !m to be    
well-in=m$ p>ticipants 9 _! heal? c>e   
decision mak+ z !y consult ) _!         

physician or o!r lic5s$ heal? c>e       
practition]2 ,:]eas ! ,c5t]s = ,m$ic>e  
,m$icaid ,s]vices is ! s+le l>ge/ payor 
= drugs 9 ! ,unit$ ,/ates2 ,:]eas1 9    
#bjaf1 ! ,c5t]s = ,m$ic>e  ,m$icaid     
,s]vices & its b5efici>ies sp5t ov] #agd
 billion on drugs cov]$ "u ,p>ts ,b &   
,d1 & #fd billion on drugs cov]$ "u     
,m$icaid1 = a total ( m ?an #bch billion
 = prescription drugs2 ,:]eas1 9 #bjag1 
drug manufactur]s sp5t ov] #e4e billion 
on prescription drug adv]tis+ ( :i*     
ne>ly #d4b billion 0 sp5t on television 
adv]tis+2 & ,:]eas ! t5 mo/ commonly    
adv]tis$ drugs h li/ prices rang+ f #ece
 to #aa1jjj p] mon? or usual c\rse (    
!rapy3 ,n[1 !re=e1 be x  ,t x is ! s5se 
( ,congress t-- 7#a7 ! effici5t         
adm9i/ration ( bo? ,m$ic>e & ,m$icaid   
encompasses ,f$]al ef=ts to a*ieve good 
value = funds sp5t 9 ! ,m$ic>e &        
,m$icaid programs2  7#b7 x has direct$ !
 ,dep>tm5t ( ,heal? & ,human ,s]vices to
 op]ate ! ,m$ic>e & ,m$icaid programs   
effici5tly2  7#c7 ! ,dep>tm5t ( ,heal? &

 ,human ,s]vices has ! au?ority to      
require direct-to-consum] 7,,dtc7       
television adv]tisem5ts ( prescription  
drugs & biological products to include !
 ,:olesale ,acquisition ,co/ 7,,wac1 or 
li/ price7 ( t drug or biological       
product "u sections #aajb & #ahga ( !   
,social ,security ,act2 &  7#d7 ! f9al  
rule titl$ ,m$ic>e & ,m$icaid ,programs3
 ,regulation ,to ,require ,drug ,pric+  
,transp>5cy publi%$ by ! ,c5t]s =       
,m$ic>e  ,m$icaid ,s]vices 9 ! ,f$]al   
,regi/] on ,may #aj1 #bjai 7#hd ,f$4    
,reg4 #bjgcb71 makes sub/antial progress
 9 improv+ drug pric+ transp>5cy2 &     
7#e7 !re %\ld be a /atute requir+ !     
inclusion ( drug pric+ in=mation 9 all  
direct-to-consum] television            
adv]tisem5ts = drugs1 includ+ biological
 products4